Cargando…
Artemisinin-naphthoquine combination (ARCO™) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: A preliminary report on safety and efficacy
BACKGROUND: The use of anti-malarial drug combinations with artemisinin or with one of its derivatives is now widely recommended to overcome drug resistance in falciparum as well as vivax malaria. The fixed oral dose artemisinin-naphthoquine combination (ANQ, ARCO™) is a newer artemisinin-based comb...
Autores principales: | Hombhanje, Francis W, Linge, David, Saweri, Adolf, Kuanch, Cynthia, Jones, Robert, Toraso, Stephen, Geita, Jacobed, Masta, Andrew, Kevau, Isi, Hiawalyer, Gilbert, Sapuri, Mathias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734862/ https://www.ncbi.nlm.nih.gov/pubmed/19671190 http://dx.doi.org/10.1186/1475-2875-8-196 |
Ejemplares similares
-
Artemisinin-Naphthoquine Combination (ARCO(®)): An Overview of the Progress
por: Hombhanje, Francis W., et al.
Publicado: (2010) -
Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
por: Isba, Rachel, et al.
Publicado: (2015) -
Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
por: Moore, Brioni R., et al.
Publicado: (2017) -
Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
por: Laman, Moses, et al.
Publicado: (2014) -
Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study
por: Laman, Moses, et al.
Publicado: (2015)